Tenor Capital Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DM
DKCM
WAM
AGM
CS
Tenor Capital Management's STLNW Position: Q1 2026 in Review
Tenor Capital Management held its Starling Oncology, Inc. Warrant (STLNW) position steady in Q1 2026 at 25,000 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #491.
Tenor Capital Management first reported a position in STLNW in Q2 2020 and has held it in 24 quarters since. The position peaked at $49K in Q4 2020. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.
- Tenor Capital Management held 25,000 shares of Starling Oncology, Inc. Warrant worth $1.09K as of Q1 2026.
- Tenor Capital Management left its Starling Oncology, Inc. Warrant share count unchanged in Q1 2026.
- Starling Oncology, Inc. Warrant made up ﹤0.01% of Tenor Capital Management's portfolio in Q1 2026, its #491 holding.
- Tenor Capital Management first reported a position in Starling Oncology, Inc. Warrant in Q2 2020 and has held it in 24 quarters since.
- Tenor Capital Management's Starling Oncology, Inc. Warrant position peaked at $49K in Q4 2020.
- 11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.
Based on Tenor Capital Management's 13F filing for Q1 2026, filed 15 May 2026.